Pfizer falls as covid pill fails in preventive therapy trial
By The Washington Post | Published May 3, 2022
Pfizer slumped after Paxlovid, its pill for treating covid-19, failed to show benefit as a preventive therapy in a trial.
International
Crypto revolution spurs central banks to design money's future
By The Washington Post | Published Apr 18, 2022
Locked-down Shanghai residents barter for what money can't buy
By The Washington Post | Published Apr 15, 2022
Germany faces $240 billion hit if Russian energy cut off
By The Washington Post | Published Apr 14, 2022
A look at how this oil tycoon made $1.2 billion
By The Washington Post | Published Apr 14, 2022
After Donald Trump's controversial courtship of Saudi Arabia, Jared Kushner gets a $2 billion investment
By The Washington Post | Published Apr 12, 2022
Zimbabwe experiments with exchange rate liberalisation
By Tawanda Karombo | Published Apr 6, 2022
Loading Trendingarticles...
Chanel stops selling bags to Russians who want to take them home
By The Washington Post | Published Apr 5, 2022
Could Elon Musk’s new stake in Twitter mean a shake-up at the social media site?
By Reuters | Published Apr 4, 2022
Exiled oligarch calls on other Russian tycoons to break with Putin
By The Washington Post | Published Apr 4, 2022
In targeted Russian economy, businesses operate without Western products
By The Washington Post | Published Apr 3, 2022
Russian regulators threaten YouTube with fines for 'information war'
By The Washington Post | Published Mar 30, 2022
Japan power crisis was a decade in making and won't go away
By The Washington Post | Published Mar 28, 2022
Microsoft says digital extortion gang Lapsus$ targets cryptocurrency, too
By The Washington Post | Published Mar 24, 2022
The rise and (maybe) fall of BuzzFeed News
By The Washington Post | Published Mar 24, 2022
